• 1
    Belldegrun A, DeKermin BJ. Renal tumors. In: Walsh PC, Retik AB, Vaughan ED, Wein A. Campbell's Urology, 7th edn. WB Saunders, Philadelphia, 1998; 2312–5.
  • 2
    Giardiello FM, Hamilton SR, Krush AJ et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med. 1993; 328: 13136.
  • 3
    Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Forrenbach S, DuBois RN. Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 1994; 107: 1183.
  • 4
    Huang M, Stolina M, Sharma S et al. Non-small lung cancer cyclooxygenase-2-dependent regulation of cytokine balance in lymphocytes and macrophages: up-regulation of interleukin-10 and down-regulation of interleukin-12 production. Cancer Res. 1998; 58: 120816.
  • 5
    Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93: 70516.
  • 6
    Von Knethen A, Brune B. Cyclooxygenase-2: an essential regulator of NO-mediated apoptosis. FASEB J. 1997; 11: 88795.
  • 7
    Giambartolomei S, Artini M, Almerighi C, Moavero MS, Levrero M, Balsano C. Nonsteroidal anti-inflammatory drug metabolism potentiates interferon alfa signaling by increasing STAT1 phosphorylation. Hepatology 1999; 30: 5106.
  • 8
    Yoshino S, Kato M, Okada K. Clinical significance of angiogenesis, proliferation and apoptosis in renal cell carcinoma. Anticancer Res. 2000; 20: 5914.